Genedrive extends global reach taking diagnostic Hepatitis-C test into Asia-Pacific

Published on 14th Nov 2017

David Budd, chief executive of the diagnostics specialist genedrive PLC (LON:GDR), tells Proactive they've extended the “commercial reach” of their relationship with Sysmex Corp, signing a distribution deal with the Japanese group’s Asia-Pacific arm.

Under the agreement, Sysmex will be responsible for sales, marketing and customer support for the CE-marked Genedrive HCV ID Kit and platform in the region.

Pharma & Biotech
Add to favorites
Share with:

Related Videos

Latest

Recommended videos

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082.
You can contact us here.

Choose Proactive Region: